期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
生物信息红外肝病治疗仪治疗慢性丙型肝炎肝硬化临床观察 被引量:1
1
作者 周箐 《实用中西医结合临床》 2014年第7期24-25,共2页
近些年,对于近红外线治疗慢性乙肝的研究多见报道,但对于慢性丙肝肝硬化辅助治疗方面的专题研究较为少见。为此,我们在常规治疗的基础上采用DSG-2型生物信息红外肝病治疗仪对28例慢性丙肝肝硬化患者的辅助疗效进行了临床观察。现报道如下:
关键词 慢性丙型肝炎肝硬化 生物信息红外肝病治疗仪 疗效观察
下载PDF
聚乙二醇干扰素治疗慢性丙肝患者的临床疗效及不良反应 被引量:3
2
作者 贾俊洋 《基层医学论坛》 2015年第17期2341-2342,共2页
目的观察聚乙二醇干扰素α-2a治疗慢性丙型肝炎肝硬化的临床疗效和不良反应。方法将80例2010年1月—2013年1月在我院诊治的慢性丙型肝炎肝硬化患者随机分为观察组和对照组,每组各40例。观察组患者采用聚乙二醇干扰素α-2a 130~180μg皮... 目的观察聚乙二醇干扰素α-2a治疗慢性丙型肝炎肝硬化的临床疗效和不良反应。方法将80例2010年1月—2013年1月在我院诊治的慢性丙型肝炎肝硬化患者随机分为观察组和对照组,每组各40例。观察组患者采用聚乙二醇干扰素α-2a 130~180μg皮下注射,每周1次,疗程12个月;对照组采用保肝、降酶等药物进行综合治疗。统计分析2组患者的治疗效果及不良反应。结果观察组治疗后肝功能均较治疗前显著改善(P〈0.05),且治疗后肝功能显著优于对照组(P〈0.05);对照组治疗前后肝功能改善不明显(P〉0.05)。观察组发生20例白细胞降低、13例血小板降低、2例甲状腺功能亢进,予以药物治疗或停用干扰素后好转。结论干扰素治疗慢性丙肝具有疗效确切、治疗方便、用药安全性良好等特点。 展开更多
关键词 慢性丙型肝炎肝硬化 干扰素 不良反应疗效
下载PDF
Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection?
3
作者 Perdita Wietzke-Braun Felix Braun +1 位作者 Peter Schott Giuliano Ramadori 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第4期745-750,共6页
AIM:To evaluate the potential of laparoscopy in the diagnosis of cirrhosis and outcome of interferon treatment in HCV-infected patients. METHODS:In this retrospective study,diagnostic laparoscopy with laparoscopic liv... AIM:To evaluate the potential of laparoscopy in the diagnosis of cirrhosis and outcome of interferon treatment in HCV-infected patients. METHODS:In this retrospective study,diagnostic laparoscopy with laparoscopic liver biopsy was performed in 72 consecutive patients with chronic HCV infection.The presence or absence of drrhosis was analyzed macroscopically by laparoscopy and microscopically by liver biopsy specimens.Clinical and laboratory data and outcome of interferon-alfa treatment were compared between cirrhotic and noncirrhotic patients. RESULTS:Laparoscopically,cirrhosis was seen in 29.2 % (21/72)and non-cirrhosis in 70.8 %(51/72)of patients. Cirrhotic patients were significantly older with a significant longer duration of HCV infection than noncirrhotic patients. Laboratory parameters(AST,y-GT,y-globulin fraction)were measured significantly higher as well as significantly lower (prothrombin index,platelet count)in cirrhotic patients than in non-cirrhotic patients.Histologically,cirrhosis was confirmed in 11.1%(8/72)and non cirrhosis in 88.9 %(64/72).Patients with macroscopically confirmed cirrhosis(n=21)showed histologically cirrhosis in 38.2 %(8/21)and histologically non- cirrhosis in 61.9 %(13/21).In contrast,patients with macroscopically non-cirrhosis(n=51)showed histologically non cirrhosis in all cases(51/51).Thirty-nine of 72 patients were treated with interferon-alfa,resulting in 35.9 %(14/39) patients with sustained response and 64.1%(25/39)with non response.Non-responders showed significantly more macroscopically cirrhosis than sustained responders.In contrast,there were no significant histological differences between non-responders and sustained responders. CONCLUSION:Diagnostic laparoscopy is more accurate than liver biopsy in recognizing cirrhosis in patients with chronic HCV infection.Liver biopsy is the best way to assess inflammatory grade and fibrotic stage.The invasive marker for staging,prognosis and management,and treatment outcome of chronic HCV-infected patients need further research and dinical thals.Laparoscopy should be performed for recognition of drrhosis if this parameter is found to be of prognostic and therapeutic relevance in patients with chronic HCV infection. 展开更多
关键词 Adult Biopsy Comparative Study Female Genotype HEPACIVIRUS purification Hepatitis C Chronic Humans INTERFERON-ALPHA LAPAROSCOPY Liver Cirrhosis Male Middle Aged RNA Viral Reproducibility of Results Retrospective Studies Treatment Outcome
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部